Antiviral treatment of cytomegalovirus infection: an update

First Report of Successful Treatment of Multidrug-Resistant Cytomegalovirus Disease with the Novel Anti-CMV Compound AIC246

(2011) D. R. Kaul et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cyclopropavir Susceptibility of Cytomegalovirus DNA Polymerase Mutants Selected after Antiviral Drug Exposure

(2011) Sunwen Chou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir

(2011) David Boutolleau et al.   ANTIVIRAL RESEARCH

Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation

(2011) Dana G. Wolf et al.   ANTIVIRAL RESEARCH

The biology of cytomegalovirus drug resistance

(2011) Morgan Hakki et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus

(2011) Clara C. Posthuma et al.   JOURNAL OF CLINICAL VIROLOGY

Cytomegalovirus quantification: Where to next in optimising patient management?

(2011) Claire Atkinson et al.   JOURNAL OF CLINICAL VIROLOGY

The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase

(2011) T. Goldner et al.   JOURNAL OF VIROLOGY

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

(2011) Francisco M Marty et al.   LANCET INFECTIOUS DISEASES

Incidence and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infections in 1244 Kidney Transplant Recipients

(2011) Hans-Arne Myhre et al.   TRANSPLANTATION

In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246

(2010) P. Lischka et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cytomegalovirus UL97 Mutations Affecting Cyclopropavir and Ganciclovir Susceptibility

(2010) Sunwen Chou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Improved Detection of Mutated Human Cytomegalovirus UL97 by Pyrosequencing

(2010) B. Schindele et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Artesunate is Ineffective in Controlling Valganciclovir-Resistant Cytomegalovirus Infection

(2010) P. Kar Han Lau et al.   CLINICAL INFECTIOUS DISEASES

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

(2010) S. Hantz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Virologic Characterization of Multidrug‐Resistant Cytomegalovirus Infection in 2 Transplant Recipients Treated with Maribavir

(2010) Lynne Strasfeld et al.   JOURNAL OF INFECTIOUS DISEASES

Deep Sequencing Reveals Highly Complex Dynamics of Human Cytomegalovirus Genotypes in Transplant Patients over Time

(2010) I. Gorzer et al.   JOURNAL OF VIROLOGY

Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection

(2010) Susanne E. Kampmann et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

(2010) Anita Schmitt et al.   TRANSFUSION

Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients

(2010) R.K. Avery et al.   Transplant Infectious Disease

Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients

(2010) J.M. Iwasenko et al.   Transplant Infectious Disease

Preemptive Versus Sequential Prophylactic-Preemptive Treatment Regimens for Cytomegalovirus in Renal Transplantation: Comparison of Treatment Failure and Antiviral Resistance

(2010) Martha T. van der Beek et al.   TRANSPLANTATION

Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study

(2010) Atul Humar et al.   TRANSPLANTATION

Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes

(2010) Robin K. Avery et al.   TRANSPLANTATION

International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

(2010) Camille N. Kotton et al.   TRANSPLANTATION

A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes

(2009) Meike Chevillotte et al.   ANTIVIRAL RESEARCH

Antiviral treatment of cytomegalovirus infection and resistant strains

(2009) Andreas Schreiber et al.   EXPERT OPINION ON PHARMACOTHERAPY